Number of Shares
644,000.00
Current Holdings Value*
$221,670.00
% of Portfolio
1.41%
Total Estimate Gain
$-85,646.40
% of Total Estimate Gain
-3.18%

Lion Point Capital, LP's Mersana Therapeutics Inc Holding Summary

As of 2025-03-31, Lion Point Capital, LP held 644,000.00 shares of Mersana Therapeutics Inc(MRSN), totaling $221,670.00. This investment constitutes 1.41% of their stock portfolio, and Lion Point Capital, LP now holds 0.52% of the outstanding Mersana Therapeutics Inc(MRSN) stock.

The initial trade took place in 2023Q1. And since then Lion Point Capital, LP has made 2 purchases of MRSN, at an average price of $2.56, for a total of 1.05 Mil shares. In addition, there have been 1 sales at an average price of $5.82 for 409,120.00 shares. Based on historical transaction data and MRSN's current price of $0.35, Lion Point Capital, LP's estimated gain on his MRSN holdings is $-85,646.40, reflecting a -3.18% gain to date.

Lion Point Capital, LP MRSN ($0.35) Holding Chart

Lion Point Capital, LP MRSN ($0.35) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1